19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 3122 Cancers

International and National Collaboration Publications and projects within past five years.

Publications

ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer

Barok, M., Le Joncour, V., Martins, A., Isola, J., Salmikangas, M., Laakkonen, P. & Joensuu, H., 2020, In : Cancer Letters. 473, p. 156-163 8 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer

Holma, R., Laatikainen, R., Orell, H., Joensuu, H., Peuhkuri, K., Poussa, T., Korpela, R. & Österlund, P., Feb 2020, In : Nutrients. 12, 2, 13 p., 407.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial

NAVIGATE ESUS Investigators, Martinez-Majander, N., Ntaios, G., Liu, Y. Y., Ylikotila, P., Joensuu, H., Saarinen, J., Tiainen, M. & Tatlisumak, T., May 2020, In : European Journal of Neurology. 27, 5, p. 841-848 8 p.

Research output: Contribution to journalArticleScientificpeer-review

Anagrelide for Gastrointestinal Stromal Tumor

Pulkka, O-P., Gebreyohannes, Y. K., Wozniak, A., Mpindi, J-P., Tynninen, O., Icay, K., Cervera, A., Keskitalo, S., Murumägi, A., Kulesskiy, E., Laaksonen, M., Wennerberg, K., Varjosalo, M., Laakkonen, P., Lehtonen, R., Hautaniemi, S., Kallioniemi, O., Schöffski, P., Sihto, H. & Joensuu, H., 1 Mar 2019, In : Clinical Cancer Research. 25, 5, p. 1676-1687 12 p.

Research output: Contribution to journalArticleScientificpeer-review

A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

Le Joncour, V., Martins, A., Puhka, M., Isola, J., Salmikangas, M., Laakkonen, P., Joensuu, H. & Barok, M., Oct 2019, In : Molecular Cancer Therapeutics. 18, 10, p. 1721-1730 10 p.

Research output: Contribution to journalArticleScientificpeer-review

Prizes

Fellow of the European Academy of Cancer Sciences

Heikki Joensuu (Recipient), 2010

Prize: Prizes and awards

GIST Hall of Fame Award

Heikki Joensuu (Recipient), 2010

Prize: Prizes and awards

Matti Äyräpään palkinto

Heikki Joensuu (Recipient), 2012

Prize: Prizes and awards

Activities

Vastaväittäjä/Opponent of doctoral dissertation

Heikki Joensuu (Opponent)
2011

Activity: Examination typesOpponent of doctoral dissertation

Syöpätautien klinikan tuki ry (External organisation)

Heikki Joensuu (Board member)
2011 → …

Activity: Membership typesMembership or other role in national/international committee, council, board

Otologien ja onkologien vuosikokous

Heikki Joensuu (Speaker: Keynote)
20 Jan 201121 Jan 2011

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

3rd Middle East Hematology and Oncology Summit

Heikki Joensuu (Speaker: Keynote)
24 Feb 201125 Feb 2011

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

Yleisöluento

Heikki Joensuu (Speaker: Keynote)
27 Apr 2011

Activity: Participating in or organising an event typesPublic Talks

Press / Media

Interview Dr. Heikki Joensuu ESMO 2014

Heikki Joensuu

27/09/2014

1 Media contribution

Press/Media: Press / Media

Uutiset: Kliinisen tutkimuksen ongelmat

Heikki Joensuu

01/11/2011

1 Media contribution

Press/Media: Press / Media

Dr. Joensuu Discusses Resistance to Imatinib in GIST

Heikki Joensuu

05/07/2011

1 Media contribution

Press/Media: Press / Media

SSGXVIII-tutkimuksen tulokset

Heikki Joensuu

10/06/2011

1 Media contribution

Press/Media: Press / Media

Dr. Joensuu Discusses the Progress of GIST Treatments

Heikki Joensuu

08/06/2011

1 Media contribution

Press/Media: Press / Media